$76.56
0.34%
Nasdaq, Oct 03, 10:07 pm CET
ISIN
US36266G1076
Symbol
GEHC

GE HealthCare Technologies Stock price

$76.56
+4.18 5.78% 1M
+4.56 6.33% 6M
-1.62 2.07% YTD
-13.32 14.82% 1Y
+16.56 27.60% 3Y
+16.56 27.60% 5Y
+16.56 27.60% 10Y
+16.56 27.60% 20Y
Nasdaq, Closing price Fri, Oct 03 2025
-0.26 0.34%
ISIN
US36266G1076
Symbol
GEHC

Key metrics

Basic
Market capitalization
$35.0b
Enterprise Value
$41.5b
Net debt
$6.6b
Cash
$3.7b
Shares outstanding
456.6m
Valuation (TTM | estimate)
P/E
15.7 | 16.6
P/S
1.8 | 1.7
EV/Sales
2.1 | 2.0
EV/FCF
26.5
P/B
3.6
Dividends
DPS
$0.14
Yield 1Y | 5Y
0.2% | 0.1%
Growth 1Y | 5Y
16.7% | -
Payout 1Y | 3Y
2.8% | 1.8%
Increased
3 Years
Financials (TTM | estimate)
Revenue
$20.0b | $20.9b
EBITDA
$3.3b | $3.7b
EBIT
$2.8b | $3.1b
Net Income
$2.2b | $2.1b
Free Cash Flow
$1.6b
Growth (TTM | estimate)
Revenue
2.3% | 6.1%
EBITDA
9.2% | 15.0%
EBIT
12.5% | 18.1%
Net Income
41.8% | 5.6%
Free Cash Flow
-3.2%
Margin (TTM | estimate)
Gross
41.6%
EBITDA
16.7% | 17.7%
EBIT
13.8%
Net
11.2% | 10.1%
Free Cash Flow
7.8%
Financial Health
Equity Ratio
25.5%
Return on Equity
23.6%
ROCE
10.7%
ROIC
8.9%
Debt/Equity
1.1
More
EPS
$4.9
FCF per Share
$3.4
Short interest
2.2%
Employees
53k
Rev per Employee
$370.0k
Show more

Create a Free Account to create an GE HealthCare Technologies alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

GE HealthCare Technologies Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a GE HealthCare Technologies forecast:

20x Buy
74%
7x Hold
26%

Analyst Opinions

27 Analysts have issued a GE HealthCare Technologies forecast:

Buy
74%
Hold
26%

Financial data from GE HealthCare Technologies

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
19,966 19,966
2% 2%
100%
- Direct Costs 11,670 11,670
1% 1%
58%
8,296 8,296
4% 4%
42%
- Selling and Administrative Expenses 4,233 4,233
0% 0%
21%
- Research and Development Expense 1,306 1,306
1% 1%
7%
3,327 3,327
9% 9%
17%
- Depreciation and Amortization 567 567
5% 5%
3%
EBIT (Operating Income) EBIT 2,760 2,760
12% 12%
14%
Net Profit 2,241 2,241
42% 42%
11%

In millions USD.

Don't miss a Thing! We will send you all news about GE HealthCare Technologies directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

GE HealthCare Technologies Stock News

Neutral
Business Wire
5 days ago
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its third quarter 2025 financial results before the market opens on Wednesday, October 29, 2025. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/ne...
Neutral
Business Wire
11 days ago
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced updates to Intelligent Radiation Therapy (iRT), a new version of the company's software solution for radiation therapy workflow management, designed to reduce the time it takes for patients to go from diagnosis to treatment. The iRT solution is AI-supported by GE HealthCare and third-party applications, and the latest featur...
Neutral
Business Wire
11 days ago
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the third quarter of 2025 payable on November 14, 2025 to all shareholders of record as of October 24, 2025. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provi...
More GE HealthCare Technologies News

Company Profile

GE Healthcare Technologies, Inc. operates as a holding company with interest in providing medical technology, pharmaceutical diagnostics and digital solutions. Its operating segments include Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded on May 16, 2022 and is headquartered in Chicago, IL.

Head office United States
CEO Peter Arduini
Employees 53,000
Founded 2022
Website www.gehealthcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today